SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-11-000016
Filing Date
2011-01-13
Accepted
2011-01-13 12:30:31
Documents
5
Period of Report
2011-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT adamis-8k_0107.htm 8-K 41044
2 FORM OF OPTION AGREEMENT ex-10_1.htm EX-10.1 108732
3 FORM OF DIRECTOR & OFFICER INDEMNITY AGREEMENT ex-10_2.htm EX-10.2 84389
4 2009 EQUITY INCENTIVE PLAN ex-10_3.htm EX-10.3 200864
5 PRESS RELEASE ex-99_1.htm EX-99.1 12850
  Complete submission text file 0001387131-11-000016.txt   449784
Mailing Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014
Business Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014 (858) 401-3984
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-26372 | Film No.: 11527020
SIC: 2834 Pharmaceutical Preparations